Related Experiment Video

Updated: May 16, 2025

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
07:25

Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids

Published on: August 18, 2023

1.5K

Correspondence: Response to Editorial on "GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC"

Soon Sun Kim1, Hyung Seok Kim2, Jae Youn Cheong1

  • 1Department of Gastroenterology, Ajou University School of Medicine; 164 Worldcup-ro, Yeongtong-gu, Suwon 16499, Republic of Korea.

Clinical and Molecular Hepatology
|April 4, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
DiagnosisHepatocellular carcinomaPrognosisRecurrenceGULP1

More Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.0K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.7K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K